HomeInsights52 Week Low Stocks

Senores Pharmaceuticals Ltd 52 Week Low

Senores Pharmaceuticals Ltd 52 Week Low

stocks purchased

₹ 3.8 Cr

Volume Transacted

(Jan 6, 2025)

stocks purchased

69.4 K

Stocks Traded

(Jan 6, 2025)

Last Updated on: Jan 06, 2025

Image

Senores Pharmaceuticals Ltd

NSE: SENORES

YEARLOW

₹ 537.65

Last updated on: Jan 06, 2025

Key Highlights

  • The 52 Week Low of Senores Pharmaceuticals Ltd is ₹ 537.65 as of 06 Jan 25 .

Company Fundamentals for Senores Pharmaceuticals Ltd

No data available

Market Price of Senores Pharmaceuticals Ltd

1M

1Y

3Y

5Y

Monitoring Senores Pharmaceuticals Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
06 Jan 2025553.7
03 Jan 2025573
02 Jan 2025572.8
01 Jan 2025571.2
31 Dec 2024568.9
30 Dec 2024557.8

Asset Value vs Market Value of Senores Pharmaceuticals Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Historical Revenue of Senores Pharmaceuticals Ltd

No data available

* All values are in crore

Historical Net Profit of Senores Pharmaceuticals Ltd

No data available

* All values are in crore

Senores Pharmaceuticals Ltd News Hub

News

Senores Pharmaceuticals makes strong debut

The scrip was listed at Rs 593.70, exhibiting a premium of 51.84% to the issue price. So f...

Read more

30 Dec 2024 10:27

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for 52 Week Low of Senores Pharmaceuticals Ltd

Why is it important to track the 52-week low of Senores Pharmaceuticals Ltd stocks?

Investors should monitor the 52-week low of Senores Pharmaceuticals Ltd stocks regularly to stay informed about significant price changes and assess the stock's performance over time. Frequent monitoring will help traders identify trends and make timely decisions.

What factors can lead to Senores Pharmaceuticals Ltd stocks hitting a 52-week low?

Factors leading to Senores Pharmaceuticals Ltd stocks hitting a 52-week low may include poor fiscal results, negative industry trends, macroeconomic issues, or management changes. Other factors such as market volatility and broader economic downturns can also contribute to a 52-week low.

Should investors buy Senores Pharmaceuticals Ltd stocks when they hit a 52-week low?

Buying Senores Pharmaceuticals Ltd stocks at a 52-week low can offer a potential bargain, however, it is crucial to evaluate the reasons behind the stock price drop and ensure there is no underlying fundamental issue. Investors should consider the company's long-term prospects before making a buying decision.

How often should investors monitor the 52-week low of Senores Pharmaceuticals Ltd stocks?

Investors should monitor the 52-week low of Senores Pharmaceuticals Ltd stocks regularly to stay informed about significant price changes and assess the stock's performance over time, which will help them identify trends and make timely decisions.

How can an investor assess the risk of buying Senores Pharmaceuticals Ltd stock at their 52-week low?

An investor can analyze the reasons for the Senores Pharmaceuticals Ltd stock price drop, evaluate the company’s fundamentals, and consider market conditions. Investors should also review the stock’s historical performance and any potential recovery indicators.

Should investors consider the overall market trend when evaluating Senores Pharmaceuticals Ltd stocks at their 52-week low?

Certainly, considering the overall market trend when evaluating Senores Pharmaceuticals Ltd stocks at their 52-week low is significant as it provides context for the stock’s performance and potential future movements. A declining market trend may influence Senores Pharmaceuticals Ltd stock performance, impacting the timing and potential of the investment.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Demat Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Demat Account
Verify your phone
+91
*By signing up you agree to our terms & conditions